Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)
CNY 2.75
(-0.36%)
CNY 2.75
(-0.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 161.22 Million | 281.01 Million | 92.68 Million | 178.52 Million | 445.81 Million | 123.89 Million |
| Net Income | -195.32 Million | 36.89 Million | -798.23 Million | 191.27 Million | 155 Million | 210.67 Million |
| Depreciation & Amortization | 208.83 Million | 176.48 Million | 197.09 Million | 184.12 Million | 153.91 Million | 130.68 Million |
| Deferred income taxes | 9.56 Million | -26.24 Million | -59.12 Million | -2.43 Million | -36.41 Million | 7.53 Million |
| Stock-based compensation | - | -9.16 Million | 15.5 Million | 17.26 Million | - | - |
| Change in working capital | 17.12 Million | -70.64 Million | -58.25 Million | -161.32 Million | 35.9 Million | -289.42 Million |
| Other non-cash items | 503.09 Million | 138.28 Million | 752.08 Million | -35.54 Million | 100.99 Million | 71.97 Million |
| Investing Cash Flow | -117.72 Million | -258.58 Million | -33.17 Million | -945.63 Million | -496.85 Million | -80.52 Million |
| Investments in PPE | -238.18 Million | -173.49 Million | -349.33 Million | -605.88 Million | -364.21 Million | -96.72 Million |
| Acquisitions | 20.11 Million | 1.41 Million | -57.23 Million | 96.7 Million | -4.4 Million | 96.83 Million |
| Investment purchases | -733 Million | -1.58 Billion | -3.32 Billion | -5.02 Billion | -1.47 Billion | -3.21 Billion |
| Sales/Maturities of investments | 833.34 Million | 1.5 Billion | 3.69 Billion | 4.58 Billion | 1.34 Billion | 3.23 Billion |
| Other Investing Activities | 133.26 Million | 400.02 Thousand | 1.23 Million | 65.19 Thousand | 1.22 Million | -96.72 Million |
| Financing Cash Flow | -166 Million | -9.36 Million | -335.24 Million | 341.66 Million | -23.16 Million | -45.09 Million |
| Debt repayment | -39.13 Million | -246 Million | -613 Million | -377 Million | -100 Million | - |
| Dividends payments | -70.09 Million | -4.72 Million | -103.13 Million | -20.42 Million | -20.62 Million | -45.09 Million |
| Common Stock Repurchased | - | - | - | -83.94 Million | - | - |
| Common Stock Issuance | - | - | - | 83.94 Million | - | - |
| Other Financing Activities | -123.5 Million | 241.35 Million | 392.67 Million | 757.05 Million | 100 Million | -3.84 Million |
| Accounts receivables | -19.95 Million | -9.1 Million | 125.93 Million | -189.49 Million | 85.61 Million | -140.54 Million |
| Accounts payables | 8.58 Million | 76.46 Million | 35.93 Million | -93.44 Million | -50.61 Million | 52.34 Million |
| Inventory | 46.96 Million | -111.76 Million | -161 Million | 57 Million | 37.31 Million | -208.76 Million |
| Other working capital | -18.46 Million | -26.24 Million | -59.12 Million | 64.61 Million | -36.41 Million | -80.66 Million |
| Cash at beginning of period | 764.66 Million | 601.57 Million | 880.29 Million | 1.31 Billion | 1.38 Billion | 1.38 Billion |
| Cash at end of period | 744.34 Million | 632.94 Million | 601.57 Million | 879.88 Million | 1.31 Billion | 1.38 Billion |
| Capital Expenditure | -238.18 Million | -173.49 Million | -349.33 Million | -605.88 Million | -364.21 Million | -96.72 Million |
| Effect of forex changes on cash | 201.12 Thousand | 18.3 Million | -2.98 Million | -9 Million | 308.22 Thousand | 6.47 Million |
| Net cash flow / Change in cash | -20.31 Million | 31.36 Million | -278.72 Million | -434.44 Million | -73.89 Million | 4.74 Million |
| Free Cash Flow | -76.95 Million | 107.52 Million | -256.64 Million | -427.36 Million | 81.6 Million | 27.17 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.76 Million | 3.39 Million | 2.9 Million | -235.39 Million | -195.32 Million | -11.87 Million |
| Depreciation & Amortization | - | 47.36 Million | 47.36 Million | 52.58 Million | 208.83 Million | -102.53 Million |
| Deferred income taxes | - | - | - | - | 9.56 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 37.36 Million | - | 8.54 Million | 17.12 Million | 2.46 Million |
| Other non-cash items | -19.65 Million | 161.74 Million | 8.45 Million | 450.01 Million | 503.09 Million | 57.61 Million |
| Investing Cash Flow | -63.94 Million | 3.29 Million | -201.28 Million | 856.7 Thousand | -117.72 Million | -57.68 Million |
| Investments in PPE | -65.07 Million | -47.55 Million | -51.67 Million | -60.26 Million | -238.18 Million | -77.45 Million |
| Acquisitions | 31.3 Thousand | - | 150 Thousand | -348 Thousand | 20.11 Million | 109.08 Thousand |
| Investment purchases | -60 Million | - | -250.2 Million | 10.12 Million | -733 Million | -140 Million |
| Sales/Maturities of investments | 60.39 Million | 50.85 Million | 100.43 Million | 51.34 Million | 833.34 Million | 159.66 Million |
| Other Investing Activities | 736.3 Thousand | 50.85 Million | -148.96 Million | 52.1 Million | 133.26 Million | 0.54 |
| Financing Cash Flow | -3.18 Million | -13.53 Million | 154.88 Million | 70.06 Million | -166 Million | -1.11 Million |
| Debt repayment | -50 Million | -10 Million | -8.7 Million | -142 Million | -39.13 Million | - |
| Dividends payments | -1.13 Million | -2.84 Million | -3.34 Million | -1.27 Million | -70.09 Million | -413.23 Thousand |
| Common Stock Repurchased | - | - | - | - | - | -16.55 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -52.04 Million | -687.48 Thousand | 146.18 Million | -68.57 Million | -123.5 Million | -700.23 Thousand |
| Accounts receivables | - | 17.2 Million | - | -19.95 Million | -19.95 Million | -8.39 Million |
| Accounts payables | - | - | - | - | 8.58 Million | - |
| Inventory | - | 754.52 Thousand | - | 46.96 Million | 46.96 Million | 7.9 Million |
| Other working capital | - | 19.41 Million | - | -18.46 Million | -18.46 Million | 2.95 Million |
| Cash at beginning of period | 574.36 Million | 469.74 Million | 744.34 Million | 501.64 Million | 764.66 Million | 410.35 Million |
| Cash at end of period | 453.78 Million | 574.36 Million | 535.04 Million | 744.34 Million | 744.34 Million | 275.14 Million |
| Capital Expenditure | -65.07 Million | -47.55 Million | -51.67 Million | -60.26 Million | -238.18 Million | -77.45 Million |
| Effect of forex changes on cash | -1.63 Million | -2.07 Million | -5.84 Million | 2.53 Million | 201.12 Thousand | -2.42 Million |
| Net cash flow / Change in cash | -120.57 Million | 104.62 Million | -209.3 Million | 242.7 Million | -20.31 Million | -135.2 Million |
| Free Cash Flow | -116.5 Million | 70.22 Million | -40.31 Million | 101.76 Million | -76.95 Million | -131.77 Million |
PLAOW
JELD
004170
QUADRANT
3691
TRUX